NICE will not recommend ‘medical’ cannabis for epilepsy and chronic pain

The National Institute for Health and Care Excellence said it is currently unable to recommend cannabis-based medical products for severe treatment-resistant epilepsy. In draft guidance, NICE said that more research is needed because clinical trials had shown a high level of adverse events.